Valproic acid-induced parkinsonism: Levodopa responsiveness with dyskinesia

Parkinsonism and Related Disorders

Volumn 19, Issue 8, 2013, Pages 758-760

  Silver, Michael ^a   Factor, Stewart A ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Dyskinesia; Parkinsonism; Valproate; Valproic acid

Indexed keywords

CARBIDOPA; CARBIDOPA PLUS LEVODOPA; ENTACAPONE; LAMOTRIGINE; LEVODOPA; PRAMIPEXOLE; VALPROIC ACID;

ADULT; AGED; ALCOHOLISM; ARTICLE; BALANCE DISORDER; BIPOLAR DISORDER; BRADYKINESIA; CASE STUDY; CLINICAL ARTICLE; DEPRESSION; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSKINESIA; FEMALE; HUMAN; LOW DRUG DOSE; MALE; MUSCLE RIGIDITY; MYOCLONUS; ONSET AGE; PARKINSONISM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEIZURE; TREATMENT DURATION; TREMOR;

ADULT; AGED; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE, SECONDARY; VALPROIC ACID;

EID: 84879411233     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2013.03.016     Document Type: Article

References (12)

1. Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs 2002, 16(10):695-714.
2. Mahmoud F., Tampi R.R. Valproic acid-induced parkinsonism in the elderly: a comprehensive review of the literature. Am J Geriatr Pharmacother 2011 Dec, 9(6):405-412.
3. van der Zwan A. Transient Parkinson syndrome and tremor caused by the use of sodium valproate. Ned Tijdschr Geneeskd 1989 Jun 17, 133(24):1230-1232.
4. Easterford K., Clough P., Kellett M., Fallon K., Duncan S. Reversible parkinsonism with normal beta-CIT-SPECT in patients exposed to sodium valproate. Neurology 2004 Apr 27, 62(8):1435-1437.
5. Zadikoff C., Munhoz R.P., Asante A.N., Politzer N., Wennberg R., Carlen P., et al. Movement disorders in patients taking anticonvulsants. JNeurol Neurosurg Psychiatry 2007 Feb, 78(2):147-151.
6. Jamora D., Lim S.H., Pan A., Tan L., Tan E.K. Valproate-induced Parkinsonism in epilepsy patients. Mov Disord 2007 Jan, 22(1):130-133.
7. Ristic A.J., Vojvodic N., Jankovic S., Sindelic A., Sokic D. The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy. Epilepsia 2006 Dec, 47(12):2183-2185.
8. Factor S. Lithium-induced movement disorders. Drug-induced movement disorders 2004, 209-231. Marcel Dekker, Inc., New York. K. Sethi (Ed.).
9. Macphee G.J., Stewart D.A. Diagnosis of Parkinsonism in older patients receiving sodium valproate. Mov Disord 2007 Jun 15, 22(8):1211.
10. Onofrj M., Thomas A., Paci C. Reversible parkinsonism induced by prolonged treatment with valproate. JNeurol 1998 Dec, 245(12):794-796.
11. Masmoudi K., Gras-Champel V., Masson H., Andrejak M. Parkinsonism and/or cognitive impairment with valproic acid therapy: a report of ten cases. Pharmacopsychiatry 2006 Jan, 39(1):9-12.
12. Nouzeilles M., Garcia M., Rabinowicz A., Merello M. Prospective evaluation of parkinsonism and tremor in patients treated with valproate. Parkinsonism Relat Disord 1999 Apr, 5(1-2):67-68.